Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Vogel

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2025
Beyond the Guided Missile Paradigm: Embracing the Complexity of Antibody-Drug ConjugatesMatthew Vogel, Raffaele Colombo, Paolo Tarantino
Science Translational Medicine|December 4, 2024
Predicting the next round of drugs for Medicare price negotiationMatthew Vogel, Adam Tellier, Rena M Conti
Nature Biotechnology|January 31, 2024
Medicare price negotiation and pharmaceutical innovation following the Inflation Reduction ActMatthew Vogel, Pragya Kakani, Amitabh Chandra, et al.
The New England Journal of Medicine|October 11, 2023
Will Medicare Price Negotiation Delay Cancer-Drug Launches?Matthew Vogel, Aaron S Kesselheim, William B Feldman, et al.
Annals of Internal Medicine|April 29, 2024
Medicare Negotiation's Drug Reformulation ProblemMatthew Vogel, Benjamin N Rome, Aaron S Kesselheim, et al.
Nature Reviews. Clinical Oncology|June 6, 2025
Surrogate end points in oncology: aligning drug development incentives and patient needsMatthew Vogel, Rona Yaeger, David J Stewart, et al.
JAMA Internal Medicine|November 27, 2023
Cost of Exempting Sole Orphan Drugs From Medicare NegotiationMatthew Vogel, Olivia Zhao, William B Feldman, et al.
JAMA|November 25, 2024
Differential Legal Protections for Biologics vs Small-Molecule Drugs in the USOlivier J Wouters, Matthew Vogel, William B Feldman, et al.
JAMA Health Forum|October 17, 2025
Revenue Differences Between Top-Selling Small-Molecule Drugs and Biologics in MedicareMatthew Vogel, William B Feldman, Zander Cowan, et al.
Journal of Public Health Management and Practice : JPHMP|March 24, 2023
A Regional Approach to Hospital-Based Violence Intervention Programs Through LOVKristen L Mueller, Kateri Chapman-Kramer, Benjamin P Cooper, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2025
Beyond the Guided Missile Paradigm: Embracing the Complexity of Antibody-Drug ConjugatesMatthew Vogel, Raffaele Colombo, Paolo Tarantino
Science Translational Medicine|December 4, 2024
Predicting the next round of drugs for Medicare price negotiationMatthew Vogel, Adam Tellier, Rena M Conti
Nature Biotechnology|January 31, 2024
Medicare price negotiation and pharmaceutical innovation following the Inflation Reduction ActMatthew Vogel, Pragya Kakani, Amitabh Chandra, et al.
The New England Journal of Medicine|October 11, 2023
Will Medicare Price Negotiation Delay Cancer-Drug Launches?Matthew Vogel, Aaron S Kesselheim, William B Feldman, et al.
Annals of Internal Medicine|April 29, 2024
Medicare Negotiation's Drug Reformulation ProblemMatthew Vogel, Benjamin N Rome, Aaron S Kesselheim, et al.
Nature Reviews. Clinical Oncology|June 6, 2025
Surrogate end points in oncology: aligning drug development incentives and patient needsMatthew Vogel, Rona Yaeger, David J Stewart, et al.
JAMA Internal Medicine|November 27, 2023
Cost of Exempting Sole Orphan Drugs From Medicare NegotiationMatthew Vogel, Olivia Zhao, William B Feldman, et al.
JAMA|November 25, 2024
Differential Legal Protections for Biologics vs Small-Molecule Drugs in the USOlivier J Wouters, Matthew Vogel, William B Feldman, et al.
JAMA Health Forum|October 17, 2025
Revenue Differences Between Top-Selling Small-Molecule Drugs and Biologics in MedicareMatthew Vogel, William B Feldman, Zander Cowan, et al.
Journal of Public Health Management and Practice : JPHMP|March 24, 2023
A Regional Approach to Hospital-Based Violence Intervention Programs Through LOVKristen L Mueller, Kateri Chapman-Kramer, Benjamin P Cooper, et al.
Pageof 1